Advanced Enzyme Technologies Limited — PPTs, 12-11-2025: Investor Presentation

Advanced Enzyme Technologies announced its consolidated financial results for the quarter and half-year. For Q2 FY26, revenue increased 26% YoY to ₹184.5 Cr, with a slight 1% QoQ dip. Profit After Tax (PAT) jumped 34% YoY to ₹44.7 Cr, and EBITDA grew 42% YoY to ₹60.1 Cr. EPS rose 32% YoY to ₹3.87.

Human Nutrition, comprising 66% of revenue, grew 22% YoY. Industrial Bio-Processing surged 52% YoY, and Specialized Manufacturing was up 54% YoY. India, Asia, and Europe delivered strong revenue growth.

The company is focused on expanding its Animal Nutrition product line and market reach, introducing more Probiotics for human and animal health, and developing Bio-Catalysis solutions for API manufacturers with several products in advanced trial stages. Global expansion for Baking Solutions remains a key priority.